The combined analyses of four LDL lowering PCSK9 gene variants finds an association with elevated fasting glucose levels and an increased risk of T2D [odds ratio of 1.29 (1.11 to 1.50)]. The gene discussed is PCSK9; the disease is type 2 diabetes mellitus.